Check out Speciality Medicines IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Speciality Medicines IPO GMP is not started in grey market, lets wait for the IPO announcement. Stay tuned for the latest IPO GMP numbers of Speciality Medicines IPO.
Speciality Medicines IPO GMP Live Rates
| Date | IPO GMP | GMP Trend | Gain |
| 21 March | ₹- | – | -% |
| 20 March | ₹- | – | -% |
| 19 March | ₹- | – | -% |
| 18 March | ₹- | – | -% |
| 17 March | ₹- | – | -% |
Speciality Medicines IPO Details
| IPO Open Date | March 20, 2026 |
| IPO Close Date | March 24, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹117 to ₹124 Per Share |
| Issue Size | Approx ₹29.14 Crores |
| Fresh Issue | Approx ₹29.14 Crores |
| Issue Type | Book build Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |
Speciality Medicines IPO Dates
| IPO Open Date: | March 20, 2026 |
| IPO Close Date: | March 24, 2026 |
| Basis of Allotment: | March 25, 2026 |
| Refunds: | March 27, 2026 |
| Credit to Demat Account: | March 27, 2026 |
| IPO Listing Date: | March 30, 2026 |
| IPO Bidding Cut-off Time: | March 24, 2026 – 5 PM |
Business Overview
Speciality Medicines Limited IPO GMP is a pharmaceutical company focused on high-value specialty drugs, particularly in areas like oncology (cancer), nephrology (kidney diseases), and critical care treatments. Unlike regular generic drug companies, it deals in specialized, high-cost medicines that are often required for serious and life-threatening conditions.
The company operates through a global sourcing and distribution model, procuring pharmaceutical products from over 40 countries and supplying them to hospitals, healthcare providers, and distributors. This strong international network helps the company maintain a diverse product portfolio and ensures availability of critical medicines across markets.
FAQs:
What is Speciality Medicines IPO GMP Today?
Speciality Medicines IPO GMP is ₹- as of today.
What is Speciality Medicines IPO Expected Returns?
Speciality Medicines IPO Expected Returns is -%.
Disclaimer:
- IPO Grey Market Premium (Speciality Medicines IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.